|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/19 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 2364691 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11157965.2 |
| Date of filing the European patent application | 2007-06-14 | |
| (97) | Date of publication of the European application | 2011-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-24 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (30) | Number | Date | Country code |
| 814484 P | 2006-06-16 | US |
| (72) |
Furfine, Eric, US
Dix, Daniel, US
Graham, Kenneth, S., US
Frye, Kelly, US
|
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | VEGF antagonisto kompozicijos tinkamos įvesti į akies stiklakūnį |
| VEGF antagonist formulations suitable for intravitreal administration |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 19 | 347.00 EUR |
| 2026-06-14 |